Orbimed Advisors Llc
- Regulatory AUM
- $20.6B
- Discretionary
- $20.6B
- Clients
- 32
- Avg AUM / client
- $644M
- Accounts
- 32
- Employees
- 118
AUM over time
Annual snapshots from Form ADV filings · as of Mar 25, 2026
Who they serve
| Client type | Clients | AUM | % of AUM |
|---|---|---|---|
| Pooled investment vehicles (non-investment companies) | 32 | $20.6B | 100.0% |
Private funds (22)
View all →Reported in Form ADV Section 7.B.(1), filing of Mar 2024 · $15.4B combined gross assets
| Fund | Type | Domicile | Gross assets | Owners |
|---|---|---|---|---|
| Orbimed Private Investments Ix, Lp | Other Private Fund | Delaware | $1.9B | 292 |
| Orbimed Asia Partners Iii, L.P. | Other Private Fund | Cayman Islands | $1.8B | 117 |
| Orbimed Private Investments Viii, Lp | Other Private Fund | Delaware | $1.7B | 186 |
| Orbimed Royalty & Credit Opportunities Iv, Lp | Private Equity Fund | Delaware | $1.5B | 405 |
| Orbimed Private Investments Vii, Lp | Other Private Fund | Delaware | $1.4B | 145 |
| Orbimed Private Investments Vi, Lp | Other Private Fund | Delaware | $1.0B | 140 |
| Orbimed Royalty & Credit Opportunities Iii, Lp | Private Equity Fund | Delaware | $968M | 113 |
| Orbimed Asia Partners Iv, L.P. | Other Private Fund | Cayman Islands | $933M | 132 |
| Orbimed Partners Master Fund Limited master | Hedge Fund | Bermuda | $775M | 195 |
| Orbimed Asia Partners V, Lp | Other Private Fund | Cayman Islands | $733M | 95 |
| Orbimed Royalty & Credit Opportunities Iv Offshore, Lp master | Private Equity Fund | Delaware | $589M | 135 |
| Orbimed Genesis Master Fund, L.P. master | Hedge Fund | Cayman Islands | $429M | 91 |
| Orbimed Israel Partners Ii, L.P. | Other Private Fund | Cayman Islands | $353M | 116 |
| Orbimed Private Investments V, Lp | Other Private Fund | Delaware | $345M | 462 |
| Orbimed Asia Partners Ii, L.P. | Other Private Fund | Cayman Islands | $213M | 415 |
People (11)
| Name | Role / title | Credentials | With firm since | Ownership |
|---|---|---|---|---|
| Borho, Sven, Heinz | Member | Jan 1998 (29y) | 25% – 50% | |
| Gordon, Carl, Lee | Member | Jan 1998 (29y) | 25% – 50% | |
| Neild, William, Carter | Member | Jan 2007 (20y) | 10% – 25% | |
| Hsu, Geoffrey, Che Chang | Member | Jan 2010 (17y) | 5% – 10% | |
| Cooper, Alexander, Matthew | General Counsel | Jul 2010 (16y) | Less than 5% | |
| Coon, Douglas, W. | Chief Compliance Officer | Feb 2016 (11y) | Less than 5% | |
| Stevens, Charles, Scotland | Member | Apr 2019 (7y) | Less than 5% | |
| Block Iii, Sam | Chief Financial Officer | May 2019 (7y) | Less than 5% | |
| Bonita, David, Paul | Member | Jan 2020 (7y) | Less than 5% | |
| Rizzo, Matthew, Scott | Member | Jan 2022 (5y) | Less than 5% | |
| Thompson, Peter, Armstrong | Member | Jan 2022 (5y) | Less than 5% |
Undisclosed: 0% – 35% of the firm is not attributable from the filed Schedule A bands.
Roster from the IAPD representatives feed; ownership and acquisition dates from Form ADV Schedule A/B. "Since" is the earliest filed registration or acquisition date.
Private funds (22, $15.4B gross assets)
| Fund | Type | Gross assets | Min. investment | Owners |
|---|---|---|---|---|
| Orbimed Private Investments Ix, Lp | Other Private Fund | $1.9B | $1.0M | 292 |
| Orbimed Asia Partners Iii, L.P. | Other Private Fund | $1.8B | $10.0M | 117 |
| Orbimed Private Investments Viii, Lp | Other Private Fund | $1.7B | $10.0M | 186 |
| Orbimed Royalty & Credit Opportunities Iv, Lp | Private Equity Fund | $1.5B | $1.0M | 405 |
| Orbimed Private Investments Vii, Lp | Other Private Fund | $1.4B | $10.0M | 145 |
| Orbimed Private Investments Vi, Lp | Other Private Fund | $1.0B | $10.0M | 140 |
| Orbimed Royalty & Credit Opportunities Iii, Lp | Private Equity Fund | $968M | $450K | 113 |
| Orbimed Asia Partners Iv, L.P. | Other Private Fund | $933M | $10.0M | 132 |
| Orbimed Partners Master Fund Limited | Hedge Fund | $775M | $1.0M | 195 |
| Orbimed Asia Partners V, Lp | Other Private Fund | $733M | $1.0M | 95 |
| Orbimed Royalty & Credit Opportunities Iv Offshore, Lp | Private Equity Fund | $589M | $500K | 135 |
| Orbimed Genesis Master Fund, L.P. | Hedge Fund | $429M | $1.0M | 91 |
| Orbimed Israel Partners Ii, L.P. | Other Private Fund | $353M | $5.0M | 116 |
| Orbimed Private Investments V, Lp | Other Private Fund | $345M | $10.0M | 462 |
| Orbimed Asia Partners Ii, L.P. | Other Private Fund | $213M | $10.0M | 415 |
| Orbimed Royalty Opportunities Ii, Lp | Hedge Fund | $210M | $750K | 272 |
| Orbimed Private Investments Iv, Lp | Other Private Fund | $101M | $10.0M | 158 |
| Orbimed Asia Partners, L.P. | Other Private Fund | $88.5M | $10.0M | 145 |
| Orbimed Partners Spv, Ltd. | Hedge Fund | $88.5M | $100K | 59 |
| Royalty Opportunities S.àr.L. | Hedge Fund | $85.4M | $10.0M | 194 |
| Orbimed New Horizons Master Fund, L.P. | Hedge Fund | $76.6M | $1.0M | 84 |
| Orbimed Israel Partners Limited Partnership | Other Private Fund | $54.4M | $5.0M | 76 |
From Form ADV Section 7.B private fund reporting.
Documents (1 archived)
| Form | Period | Size | |
|---|---|---|---|
| Form ADV (full filing) | 03/25/2026 | 6.79 MB | View · PDF · Source ↗ |
Archived copies of the firm's regulatory filings, versioned by content hash.
Disciplinary disclosures
No disciplinary events reported on the firm's latest Form ADV filing.
How they charge
- • Percentage of assets under management
- • Performance-based fees
Services
- • Portfolio management for pooled investment vehicles
Custody
Firm reports having custody of client funds or securities (Item 9.A).
No custodian data reported or mined yet.
Source
All data on this page comes from this firm's Form ADV filings, reproduced without modification. Latest filing: Mar 25, 2026.
View current Form ADV (SEC/IAPD) ↗